Get the Stockscreener App
1.35
6.25%
-0.09
Intercure Ltd stock is traded at $1.35, with a volume of 56,480.
It is down -6.25% in the last 24 hours and down -20.59% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
See More
Previous Close:
$1.44
Open:
$1.36
24h Volume:
56,480
Relative Volume:
1.75
Market Cap:
$63.16M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
10.24
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
+1.21%
1M Performance:
-20.59%
6M Performance:
-57.41%
1Y Performance:
+9.76%
1-Day Range:
$1.34
$1.40
1-Week Range:
$1.29
$1.44
52-Week Range:
$1.17
$3.72
Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.35 | 63.16M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
InterCure Ltd. (NASDAQ:INCR) Short Interest Update - MarketBeat
InterCure Ltd. (NASDAQ:INCR) Sees Significant Drop in Short Interest - MarketBeat
InterCure Ltd. (NASDAQ:INCR) Sees Large Decline in Short Interest - MarketBeat
Synbiotic's CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure - Business of Cannabis -
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
InterCure Ltd. (NASDAQ:INCR) Sees Significant Increase in Short Interest - MarketBeat
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany - Benzinga
InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war - Green Market Report
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewswire
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
InterCure partners with Cookies to launch cannabis pharmacies in Germany By Investing.com - Investing.com Australia
InterCure partners with Cookies to launch cannabis pharmacies in Germany - Investing.com
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire
InterCure (NASDAQ:INCR) Stock Price Up 0.5% - MarketBeat
Tidal Investments LLC Invests $883,000 in InterCure Ltd. (NASDAQ:INCR) - American Banking and Market News
Cannabis News: Majority of Americans Want Rescheduling or Legalization; European Market Growth Could be Game-Changer; Spotlight on InterCure - Market Research Record
Support for Regulatory Changes Surrounding Cannabis Remains Strong in the US, Companies Like InterCure Could Also Benefit From Growth in Europe - Markets Herald
Mirae Asset Global Investments Co. Ltd. Sells 467,995 Shares of InterCure Ltd. (NASDAQ:INCR) - Defense World
InterCure Ltd. (NASDAQ:INCR) Stake Cut by Mirae Asset Global Investments Co. Ltd. - MarketBeat
InterCure (NASDAQ:INCR) Shares Up 1% - MarketBeat
InterCure (NASDAQ:INCR) Trading 1% Higher - Defense World
InterCure: A Cannabis Industry Leader Still Flying Under The Radar (NASDAQ:INCR) - Seeking Alpha
InterCure (NASDAQ:INCR) Trading Down 1.2% - MarketBeat
The market capitalization of InterCure chaired by Ehud Barak is 1.000 billion shekels - Aurora Israel
IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure - Business of Cannabis -
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ - Markets Insider
The Daily Hit: May 23, 2024 - Green Market Report
Analyst: Israel’s InterCure paving path to big gains - Green Market Report
InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference - Business Wire
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - Yahoo Finance
InterCure (NASDAQ:INCR) Shares Down 4.1% - MarketBeat
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion - Benzinga
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire
InterCure: Bargain Israel Cannabis Play (NASDAQ:INCR) - Seeking Alpha
Here's What You Missed in Cannabis, Psychedelics This WeekTipRanks.com - TipRanks
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint - Business Wire
InterCure Provides Update Regarding Nir Oz Facility in Israel - Cannabis Business Times
InterCure advances restoration of Israeli site amid conflict By Investing.com - Investing.com Canada
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain - GlobeNewswire
Israeli Cannabis Firms Navigate Challenges Amid Hamas Conflict, Cellular Goods Signs New Joint Venture, & More from SEED Innovations - Business of Cannabis -
InterCure Provides an Update Regarding the Security Situation in Israel - Financial Post
Israeli Cannabis Adjusts to War - Green Market Report
Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK - Business of Cannabis -
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY - GlobeNewswire
IM Cannabis Faces NASDAQ Delisting for Second Time Despite Stock Consolidation & Israeli Cannabis Stocks Jump ... - Business of Cannabis -
InterCure: Leader In Israel's Growing Medical Cannabis Market (NASDAQ:INCR) - Seeking Alpha
InterCure Decides to Leave Toronto Stock Exchange - Green Market Report
InterCure Ltd. Announces Proposed Voluntary Delisting from - GlobeNewswire
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):